Trajectory Analysis of Symptom Distress and Cancer-related Fatigue After Adjuvant Chemotherapy in Breast Cancer Female

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-29

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

When receiving adjuvant chemotherapy, a variety of symptoms will appear and it is very painful. These symptoms occur at the same time and are related to each other. The symptom distress may affect the patient's compliance with adjuvant chemotherapy and whether the adjuvant chemotherapy can be completed on schedule. Among the symptoms of trouble, cancer-related fatigue is the most common, and the incidence can be as high as 99%. In this study, I want to track the population of breast cancer patients receiving adjuvant chemotherapy, and women in the control group who receive only anti-hormonal breast cancer or carcinoma in situ. During the treatment period, at different time points, it also collects subjective symptom distress changes and changes. The study aimed cancer-related exhaustion is measured to gain a deeper understanding of the effects of symptom troubles suffered by patients during treatment. We also hoped that in the future, it can be provided to colleagues in clinical work and can be given to breast cancer patients receiving adjuvant chemotherapy and increased holistic care quality.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Change of Fatigue and Physical Fitness in Hospitalized Hematology Patients

NCT01603290

Acute Leukemia

UNKNOWN

Adjuvant Acupuncture Care for Breast Cancer Patients Experiencing Side Effects From Chemotherapy

NCT00885183

Breast Cancer

TERMINATED NA

Sense of Hope Alleviates Fatigue in Breast Cancer Survivors

NCT02393105

Carcinoma of Male Breast

UNKNOWN

Precise Care for Cancer Related Fatigue

NCT04843657

Cancer-Related Condition

UNKNOWN

The Effect of Appropriate Family Companionship on the Physical and Mental Health of Patients With Advanced Breast Cancer

NCT06385665

Breast Cancer

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Symptom Distress During Breast Cancer Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

breast adenocarcinoma

1. The surgical pathological tissue report confirms the diagnosis of breast adenocarcinoma women with stage I\~III
2. Those who are admitted to the hospital and receive adjuvant chemotherapy for the first time.
3. Age (inclusive) over 20 years old.

breast adenocarcinoma receiving chemotherapy

Intervention Type BEHAVIORAL

for chemotherapy

Control

1. The surgical pathological tissue report establishes women diagnosed as stage 0 to stage III breast cancer
2. Those who are admitted to the hospital to receive anti-hormonal drug treatment.
3. Age (inclusive) over 20 years old.

Control-for

Intervention Type BEHAVIORAL

hormonal drug treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

breast adenocarcinoma receiving chemotherapy

for chemotherapy

Intervention Type BEHAVIORAL

Control-for

hormonal drug treatment

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

hormonal drug treatment

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The surgical pathological tissue report confirms that the diagnosis is zero stage breast carcinoma in situ women and stage I\~III Breast cancer women.
2. Those who are admitted to the hospital for the first time adjuvant chemotherapy or hormonal therapy.
3. Age (inclusive) over 20 years old